Verition Fund Management LLC Cogent Biosciences, Inc. Transaction History
Verition Fund Management LLC
- $13 Billion
- Q1 2024
A detailed history of Verition Fund Management LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 10,848 shares of COGT stock, worth $89,387. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,848Holding current value
$89,387% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding COGT
# of Institutions
159Shares Held
102MCall Options Held
197KPut Options Held
102K-
Kynam Capital Management, LP Princeton, NJ8.5MShares$70 Million5.99% of portfolio
-
State Street Corp Boston, MA7.63MShares$62.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.69MShares$55.1 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct6.68MShares$55 Million0.11% of portfolio
-
Commodore Capital LP New York, NY6.43MShares$52.9 Million3.73% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $542M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...